This week we received a majority of COVID-19 related claims on our Whatsapp tip line (9999499044) for verification. Queries ranged from misleading claims of Remdesivir being available on Pradhan Mantri Bhartiya Jan Aushadhi Kendras for Rs 899 to Bharat Biotech’s Covaxin approved for children above 12 years.
Remdesivir Cannot Be Purchased From Pradhan Mantri Bhartiya Jan Aushadhi Kendras At Rs 899
Remdesivir is to be used only for serious COVID-19 patients in the hospitals, and not for use at home. And of the seven companies licensed to produce the antiviral drug, only Zydus Cadila sells it at Rs 899.
Video On Presence Of Cockroaches In Chocolates Is Misleading
The video exaggerates facts on how authoritative bodies arrive at conclusions on food safety standards and impurities in chocolates. As per FSSAI standards, chocolate should be free from insects and other contaminants.
Bharat Biotech’s Covaxin NOT Approved For Children Above 12 Years, It’s In Trial Stage
“India’s drug regulator has given Bharat Biotech the permission to conduct clinical trials of its Covid-19 vaccine, Covaxin, on children between the age of 2 and 18, paving way for the first coronavirus inoculation to be tested in minors in the country,” reads a Hindustan Times report.
Claims on 5G Testing Radiation Being The Cause Of India’s Second COVID-19 Wave Are False
The claim on 5G testing towers being the cause of the second COVID-19 wave in India is unsubstantiated and lacks scientific evidence.